Literature DB >> 8777284

The pathomorphological alterations of endocardial endothelium in experimental diabetes and diabetes associated with hyperlipidemia.

D Popov1, A Sima, D Stern, M Simionescu.   

Abstract

The structural alterations of endocardial endothelial cells of the heart right atrium and left ventricle were investigated in Golden Syrian hamsters subjected to streptozotocin-induced diabetes and to a combination of diabetes and diet-induced hyperlipidemia. Animals were examined at time intervals ranging from 2 weeks to 6 months. Anionic sites of the endothelial plasmalemma were visualized by in situ perfusion of cationized ferritin. The results indicated that: (a) both atrial and ventricular endocardial endothelium are affected in streptozotocin-induced diabetes: endothelium converts from continuous into a fenestrated type, (b) although the anionic charge of the plasmalemma decreased in advanced diabetes, the newly formed fenestrae highly bound cationized ferritin, (c) combined diabetes and hyperlipidemia induced more severe alterations of endocardial endothelium: new permeable endothelial structures were formed (transendothelial channels, open intercellular junctions, fused plasmalemmal vesicles), and the cells became particularly enriched in cytoskeleton (intermediate filaments and microtubules), (d) the thick subendocardial layer of connective tissue contained, in the combined experimental model, macrophage derived foam cells indicative for the occurrence of alterations of atherosclerotic type.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8777284     DOI: 10.1007/bf00571939

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  26 in total

1.  Factors released from endocardium of the ferret and pig modulate myocardial contraction.

Authors:  J A Smith; A M Shah; M J Lewis
Journal:  J Physiol       Date:  1991-08       Impact factor: 5.182

Review 2.  Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.

Authors:  K Pyörälä; G De Backer; I Graham; P Poole-Wilson; D Wood
Journal:  Atherosclerosis       Date:  1994-10       Impact factor: 5.162

3.  Ultrastructure of retinal vessels in diabetic patients.

Authors:  T Ishibashi; H Inomata
Journal:  Br J Ophthalmol       Date:  1993-09       Impact factor: 4.638

4.  The hyperlipidemic hamster as a model of experimental atherosclerosis.

Authors:  A Nistor; A Bulla; D A Filip; A Radu
Journal:  Atherosclerosis       Date:  1987-11       Impact factor: 5.162

5.  Endocardial endothelium modulates cardiac responses to histamine and impromidine in isolated working right ventricle of guinea pigs.

Authors:  G X Chu; Y Zhang; Z G Guo
Journal:  Zhongguo Yao Li Xue Bao       Date:  1993-05

6.  Endocardial endothelium in the rat: cell shape and organization of the cytoskeleton.

Authors:  L J Andries; D L Brutsaert
Journal:  Cell Tissue Res       Date:  1993-07       Impact factor: 5.249

7.  Characterization of positive inotropic effect of endothelin on mammalian ventricular myocardium.

Authors:  M Takanashi; M Endoh
Journal:  Am J Physiol       Date:  1991-09

8.  Intact microtubules are necessary for complete processing, storage and regulated secretion of von Willebrand factor by endothelial cells.

Authors:  S Sinha; D D Wagner
Journal:  Eur J Cell Biol       Date:  1987-06       Impact factor: 4.492

9.  The role of oxidation and glycation in the pathogenesis of diabetic atherosclerosis.

Authors:  R O'Brien; K Timmins
Journal:  Trends Endocrinol Metab       Date:  1994-10       Impact factor: 12.015

10.  Loss of glomerular anionic sites and the development of albuminuria in rats with streptozotocin-induced diabetes.

Authors:  T Moriya; K Nakazawa; N Itoh; H Shigematsu; N Okada; T Aizawa; T Yamada; Y Yajima
Journal:  Nephron       Date:  1993       Impact factor: 2.847

View more
  7 in total

Review 1.  Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy.

Authors:  Rokhsana Mortuza; Subrata Chakrabarti
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 2.  Pulmonary vascular dysfunction in metabolic syndrome.

Authors:  Conor Willson; Makiko Watanabe; Atsumi Tsuji-Hosokawa; Ayako Makino
Journal:  J Physiol       Date:  2018-09-12       Impact factor: 5.182

3.  Age-dependent accumulation of advanced glycation endproducts is accelerated in combined hyperlipidemia and hyperglycemia, a process attenuated by L-arginine.

Authors:  A Georgescu; D Popov
Journal:  J Am Aging Assoc       Date:  2000-01

4.  Unmasking Silent Endothelial Activation in the Cardiovascular System Using Molecular Magnetic Resonance Imaging.

Authors:  Julie Belliere; Sara Martinez de Lizarrondo; Robin P Choudhury; Aurélien Quenault; Audrey Le Béhot; Christine Delage; Dominique Chauveau; Joost P Schanstra; Jean-Loup Bascands; Denis Vivien; Maxime Gauberti
Journal:  Theranostics       Date:  2015-08-08       Impact factor: 11.556

Review 5.  Reactive Oxygen Species, Endoplasmic Reticulum Stress and Mitochondrial Dysfunction: The Link with Cardiac Arrhythmogenesis.

Authors:  Gary Tse; Bryan P Yan; Yin W F Chan; Xiao Yu Tian; Yu Huang
Journal:  Front Physiol       Date:  2016-08-03       Impact factor: 4.566

6.  The Effects of Diabetes Induction on the Rat Heart: Differences in Oxidative Stress, Inflammatory Cells, and Fibrosis between Subendocardial and Interstitial Myocardial Areas.

Authors:  Maria C Guido; Alyne F Marques; Elaine R Tavares; Marcelo D Tavares de Melo; Vera M C Salemi; Raul C Maranhão
Journal:  Oxid Med Cell Longev       Date:  2017-07-11       Impact factor: 6.543

7.  Effect of ivabradine on endothelial function in diastolic and right heart failure patients.

Authors:  Arturo Orea-Tejeda; Karla Balderas-Muñoz; Lilia Castillo-Martínez; Oscar Infante-Vázquez; Raúl Martínez Memije; Candace Keirns-Davis; Joel Dorantes-García; René Narváez-David; Zuilma Vázquez-Ortíz
Journal:  Cardiol Res Pract       Date:  2013-10-03       Impact factor: 1.866

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.